A first-of-its-kind comprehensive clinical study using Stemedica's MCT (Multiple Cell Technology) adult stem cells and the Lumenis SRT laser for the treatment of macular degeneration
Latest Information Update: 17 Jun 2014
At a glance
- Drugs Retinal pigment epithelial cell replacement therapy-Stemedica Cell Technologies (Primary)
- Indications Macular degeneration
- Focus Adverse reactions
Most Recent Events
- 17 Jun 2014 New trial record